Sphera Funds Management Ltd. Galera Therapeutics, Inc. Transaction History

Sphera Funds Management Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 17, 2021	SELL	$6.08 - $10.44 $1.97 Million - $3.38 Million	-323,348 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$8.35 - $12.39 $1.21 Million - $1.79 Million	-144,314 Reduced 30.86%	323,348 $2.85 Million
Q4 2020 Feb 16, 2021	SELL	$8.02 - $12.81 $12,695 - $20,278	-1,583 Reduced 0.34%	467,662 $4.78 Million
Q2 2020 Aug 13, 2020	SELL	$7.14 - $14.41 $45,924 - $92,685	-6,432 Reduced 1.35%	469,245 $3.35 Million
Q1 2020 May 14, 2020	BUY	$5.89 - $17.67 $24,961 - $74,885	4,238 Added 0.9%	475,677 $4.52 Million

Q4 2019 Feb 13, 2020	BUY	$9.13 - $13.9 $4.3 Million - $6.55 Million	471,439 New	471,439 $6.2 Million

10.7M

10.3K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $3.76M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.